Category Archives: Pain Medications

Tanezumab, Tulranumab Trials Approved by FDA

Published by:

FDA panel says yes to resuming osteoarthritis pain drug trials: The advisory panel to the federal agency recommends allowing drugmakers to continue tests for promising anti-nerve growth factor drugs, even if these have been linked to bone decay in previous trials.

A new class of drugs called anti-nerve growth factor (anti-NGF) drugs work precisely as their name implies — by blocking proteins called nerve growth factors that are associated with nerve pain. These new medications have the potential to become the first biotechnology drugs that specifically target pain.

The new medications are potentially breakthrough drugs for the treatment of osteoarthritis, cancer pain, lower back pain, thermal burn injury, vertebral fracture, diabetic peripheral neuropathy, post-herpetic neuralgia, endometriosis, chronic pancreatitis, interstitial cystitis — and other chronic pain conditions.

Continue reading